SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-284270
Filing Date
2022-11-14
Accepted
2022-11-14 13:38:25
Documents
47
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d409952d10q.htm   iXBRL 10-Q 902440
2 EX-31.1 d409952dex311.htm EX-31.1 10435
3 EX-31.2 d409952dex312.htm EX-31.2 10338
4 EX-32.1 d409952dex321.htm EX-32.1 4479
5 EX-32.2 d409952dex322.htm EX-32.2 4487
  Complete submission text file 0001193125-22-284270.txt   4507875

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kvsa-20220930.xsd EX-101.SCH 34789
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kvsa-20220930_cal.xml EX-101.CAL 21711
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kvsa-20220930_def.xml EX-101.DEF 211304
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kvsa-20220930_lab.xml EX-101.LAB 252240
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kvsa-20220930_pre.xml EX-101.PRE 250435
41 EXTRACTED XBRL INSTANCE DOCUMENT d409952d10q_htm.xml XML 780096
Mailing Address 2128 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2128 SAND HILL ROAD MENLO PARK CA 94025 650-376-8500
Khosla Ventures Acquisition Co. (Filer) CIK: 0001841873 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40131 | Film No.: 221383408
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences